Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,289 | 4,491 | 4,751 | 3,193 | 5,413 |
| Receivables | 2,661 | 4,672 | 3,378 | 3,496 | 3,296 |
| Inventories | 6,694 | 6,546 | 6,704 | 5,013 | 4,802 |
| TOTAL | $17,475 | $15,882 | $15,317 | $12,195 | $14,538 |
| Non-Current Assets | |||||
| PPE Net | 5,986 | 6,197 | 6,345 | 6,649 | 6,784 |
| Intangibles | 6,634 | 6,634 | 6,634 | 6,634 | 6,634 |
| Other Non-Current Assets | 1,852 | 1,911 | 1,697 | 711 | 709 |
| TOTAL | $14,472 | $14,742 | $14,676 | $13,995 | $14,127 |
| Total Assets | $31,947 | $30,624 | $29,993 | $26,190 | $28,665 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 400 | 511 | 583 | 411 | 502 |
| Accounts payable and accrued liabilities | 1,284 | 1,790 | 2,052 | 930 | 701 |
| Accrued Expenses | 4,026 | 3,779 | 3,941 | 4,271 | 4,605 |
| TOTAL | $5,878 | $6,304 | $6,795 | $5,813 | $7,242 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,433 | 1,473 | 1,664 | 1,741 | 2,745 |
| Deferred Revenues | 13 | 13 | 13 | 13 | 13 |
| Other Non-Current Liabilities | 1,811 | 2,307 | 2,790 | 2,439 | 1,991 |
| TOTAL | $3,279 | $3,818 | $4,496 | $4,225 | $4,792 |
| Total Liabilities | $9,157 | $10,122 | $11,291 | $10,038 | $12,035 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,011,282 | 1,011,282 | 1,011,282 | 1,009,177 | 1,009,177 |
| Common Shares | 1,011 | 1,011 | 1,011 | 1,009 | 1,009 |
| Retained earnings | -142,489 | -144,772 | -146,569 | -148,958 | -148,475 |
| Other shareholders' equity | -307 | -307 | -307 | -307 | -307 |
| TOTAL | $22,790 | $20,503 | $18,701 | $16,152 | $16,631 |
| Total Liabilities And Equity | $31,947 | $30,624 | $29,993 | $26,190 | $28,665 |